These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4769514)

  • 21. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercalcemia after renal transplantation.
    Schwartz GH; David DS; Riggio RR; Saville PD; Whitsell JC; Stenzel KH; Rubin AL
    Am J Med; 1970 Jul; 49(1):42-51. PubMed ID: 4914475
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocalcemia associated with metastatic bone disease. A retrospective study.
    Raskin P; McClain CJ; Medsger TA
    Arch Intern Med; 1973 Oct; 132(4):539-43. PubMed ID: 4742409
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum concentrations of parathyroid hormone in infants, children, and adolescents.
    Root A; Gruskin A; Reber RM; Stopa A; Duckett G
    J Pediatr; 1974 Sep; 85(3):329-36. PubMed ID: 4372552
    [No Abstract]   [Full Text] [Related]  

  • 26. Inverse relationship between serum calcium concentration and serum lactic dehydrogenase activity.
    Stoner RE; Williams JB; Conner TB; Brager SH
    Metabolism; 1971 May; 20(5):464-73. PubMed ID: 5580872
    [No Abstract]   [Full Text] [Related]  

  • 27. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
    Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
    Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of subtotal parathyroidectomy and in situ preservation of the remnant on the metabolic and cardiac manifestations of secondary hyperparathyroidism.
    Koç O; Nart A; Doğan M; Yildirim Y; Ozbakkaloğlu M; Uslu A
    Transplant Proc; 2002 Sep; 34(6):2046-8. PubMed ID: 12270309
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
    Reutter FW; Sieber R; Olah AJ; Dambacher MA
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1880-3. PubMed ID: 531567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous remission of severe hyperparathyroidism in chronic renal failure.
    Charhon S; Sellem C; Meunier PJ; Traeger J
    Nephron; 1983; 33(1):53-5. PubMed ID: 6835455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.
    Fournier A; Moriniere P; Sebert JL; Dkhissi H; Atik A; Leflon P; Renaud H; Gueris J; Gregoire I; Idrissi A
    Kidney Int Suppl; 1986 Feb; 18():S114-9. PubMed ID: 3457987
    [No Abstract]   [Full Text] [Related]  

  • 32. Parathyroid function after kidney allografting.
    Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
    Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary hyperparathyroidism. Preoperative evaluation and correlation with surgical findings.
    Dunegan LJ; Watson CG; Kaufman SS; Pallotta J; Steichen FM
    Am J Surg; 1974 Oct; 128(4):471-7. PubMed ID: 4370675
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydroxyproline in the dialysate as a parameter of secondary hyperparathyroidism. Effects of phosphate reduction and alkalization].
    Schiessl JH; Schweigart U; Bottermann P; Kopp KF
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1310-3. PubMed ID: 25525
    [No Abstract]   [Full Text] [Related]  

  • 40. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.